Aquiluna Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Kanpur, Uttar Pradesh, India, established in 2019.
2019 Kanpur, Uttar Pradesh, India Active
Last Updated:
Access Report
About Aquiluna Pharmaceuticals Private Limited

Aquiluna Pharmaceuticals Private Limited, a active private limited company, was established on 25 November 2019 in Kanpur, Uttar Pradesh, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24299UP2019PTC123790. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Chetan Shukla (Director), Archana Tripathi (Director). Past directors included Alpana Tripathi. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No. 722-A W-2 Juhi Kalan Damodar Nagar, Kanpur, Uttar Pradesh, 208027.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24299UP2019PTC123790

  • Registration Number

    123790

  • Incorporation Date

    25 November 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 2 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** 77.69%
  • Profit Growth **** 55.11%
  • Ebitda **** 4528.34%
  • Net Worth -5.69%
  • Total Assets **** 143.13%
Company report

Aquiluna Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aquiluna Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Aquiluna Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Chetan Shukla Director 25 Nov 2019 Current
Archana Tripathi Director 15 Jan 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Jan 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aquiluna Pharmaceuticals.

Aquiluna Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 77.69% increase. The company also saw a substantial improvement in profitability, with a 55.11% increase in profit. The company's net worth dipped by a decrease of 5.69%.

Aquiluna Pharmaceuticals revenue growth over time
Aquiluna Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 77.69%
*******
*******
*******
*******
Revenue from Operations
*******
 77.47%
*******
*******
*******
*******
Total Assets
*******
 143.13%
*******
*******
*******
*******
Profit or Loss
*******
 55.11%
*******
*******
*******
*******
Net Worth
*******
 -5.69%
*******
*******
*******
*******
EBITDA
*******
 4528.34%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aquiluna Pharmaceuticals?

Unlock access to Aquiluna Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aquiluna Pharmaceuticals?

Unlock and access historical data on people associated with Aquiluna Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aquiluna Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aquiluna Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aquiluna Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    Archana Tripathi was appointed as a Director was appointed as a Director on 15 Jan 2025 & has been associated with this company since 1 year 25 days . was recorded as a recent event.

  • Annual General Meeting

    Aquiluna Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Aquiluna Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.

  • Director Appointment

    Progress on Chetan Shukla was appointed as a Director was appointed as a Director on 25 Nov 2019 & has been associated with this company since 6 years 2 months . was documented.

  • Company Incorporation

    The activity Aquiluna Pharmaceuticals Private Limited was registered on 25 Nov 2019 with Roc Kanpur & aged 6 years 2 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aquiluna Pharmaceuticals Private Limited?

The CIN of Aquiluna Pharmaceuticals Private Limited is U24299UP2019PTC123790.

Where is Aquiluna Pharmaceuticals Private Limited headquartered?

Aquiluna Pharmaceuticals Private Limited is headquartered at House No. 722-A W-2 Juhi Kalan Damodar Nagar, Kanpur, Uttar Pradesh, 208027.

When was Aquiluna Pharmaceuticals Private Limited incorporated?

Aquiluna Pharmaceuticals Private Limited was incorporated on 25 November 2019.

Who are the current directors of Aquiluna Pharmaceuticals Private Limited?

The current directors of Aquiluna Pharmaceuticals Private Limited are

What is the primary industry of Aquiluna Pharmaceuticals Private Limited?

The primary industry of Aquiluna Pharmaceuticals Private Limited is Chemicals.

Is Aquiluna Pharmaceuticals Private Limited a listed company?

Aquiluna Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Aquiluna Pharmaceuticals Private Limited?

The authorized capital of Aquiluna Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available